GlassScriptPhysician profile
Bridgette A Woodall
NPI 1558718650
$3,666.02
in general payments reported to CMS, 2019-2025
24 companies · $99.56 in 2025
The $99.56 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $682 · 2022: $246 · 2023: $2,430 · 2024: $208 · 2025: $99.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,631 · Food and Beverage: $1,087 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,631.34 |
| Food and Beverage | $1,087.14 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,610.37 | 2021-2023 | Axonics |
| Pfizer INC. | $199.02 | 2021-2023 | |
| Abbvie INC. | $192.54 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $109.04 | 2023-2024 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $91.21 | 2021-2024 | Veozah |
| Myovant Sciences INC. | $73.01 | 2021-2022 | |
| Organon LLC | $50.55 | 2021-2025 | Nexplanon |
| Amgen INC. | $37.22 | 2024 | Prolia, Evenity |
| Novo Nordisk INC | $32.83 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Kowa Pharmaceuticals America, INC. | $28.18 | 2025 | Zoryve |
| Harmony Biosciences LLC | $25.33 | 2025 | |
| Boston Scientific Corporation | $22.38 | 2022 | |
| Ferring Pharmaceuticals INC. | $21.11 | 2021 | |
| Agile Therapeutics, INC. | $20.73 | 2021 | |
| Urovant Sciences INC | $20.07 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $17.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.22 | 2024 | Airsupra |
| Exact Sciences Corporation | $15.43 | 2023 | Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $15.12 | 2021 | |
| Convatec INC. | $15.07 | 2023 | |
| Organogenesis INC. | $13.81 | 2025 | Via Matrix |
| Lilly USA, LLC | $13.65 | 2025 | Kisunla |
| Medtronic, INC. | $12.75 | 2022 | |
| Aspira Women'S Health INC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Woodall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.